NCT01053429View on ClinicalTrials.gov

A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule

CompletedOBSERVATIONAL

Enrollment

3,391

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

Bipolar DisorderSchizophrenia

Interventions

DRUG

ziprasidone

This is a non-interventional, pharmacovigilance study, therefore patients are on ziprasidone as prescribed by their doctor.

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT01053429 - A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule | Biotech Hunter | Biotech Hunter